Simply Wall St.
Does Tyra Biosciences (TYRA) Index Inclusion Mark a Turning Point in Its Institutional Story?
➖
AI Sentiment
Neutral
4/10
- Home
- TYRA
as of 12-30-2025 3:37pm EST
$25.49
+$0.02
+0.08%
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | CARLSBAD |
| Market Cap: | 1.2B | IPO Year: | 2021 |
| Target Price: | $32.17 | AVG Volume (30 days): | 516.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.88 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.42 - $26.34 | Next Earning Date: | 11-05-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered TYRA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 62.67%
62.67%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Tyra Biosciences Inc. (TYRA)
Bensen Daniel
Sell
Chief Discovery Officer
TYRA Dec 12, 2025
Avg Cost/Share
$22.64
Shares
8,000
Total Value
$181,159.20
Owned After
162,981
SEC Form 4
MORE ROBERT J
Sell
Director
TYRA Nov 21, 2025
Avg Cost/Share
$20.25
Shares
246,871
Total Value
$5,000,026.49
Owned After
3,833,425
SEC Form 4
Bensen Daniel
Sell
Chief Operating Officer
TYRA Nov 19, 2025
Avg Cost/Share
$16.32
Shares
49,956
Total Value
$815,296.91
Owned After
162,981
SEC Form 4
Bensen Daniel
Sell
Chief Operating Officer
TYRA Nov 18, 2025
Avg Cost/Share
$16.07
Shares
75,633
Total Value
$1,215,626.52
Owned After
162,981
SEC Form 4
Bensen Daniel
Sell
Chief Operating Officer
TYRA Nov 17, 2025
Avg Cost/Share
$16.59
Shares
20,072
Total Value
$324,798.16
Owned After
162,981
Bensen Daniel
Sell
Chief Operating Officer
TYRA Nov 14, 2025
Avg Cost/Share
$16.02
Shares
110,228
Total Value
$1,765,488.81
Owned After
162,981
SEC Form 4
Bensen Daniel
Sell
Chief Operating Officer
TYRA Nov 13, 2025
Avg Cost/Share
$16.00
Shares
1,111
Total Value
$17,780.00
Owned After
162,981
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Bensen Daniel | TYRA | Chief Discovery Officer | Dec 12, 2025 | Sell | $22.64 | 8,000 | $181,159.20 | 162,981 | |
| MORE ROBERT J | TYRA | Director | Nov 21, 2025 | Sell | $20.25 | 246,871 | $5,000,026.49 | 3,833,425 | |
| Bensen Daniel | TYRA | Chief Operating Officer | Nov 19, 2025 | Sell | $16.32 | 49,956 | $815,296.91 | 162,981 | |
| Bensen Daniel | TYRA | Chief Operating Officer | Nov 18, 2025 | Sell | $16.07 | 75,633 | $1,215,626.52 | 162,981 | |
| Bensen Daniel | TYRA | Chief Operating Officer | Nov 17, 2025 | Sell | $16.59 | 20,072 | $324,798.16 | 162,981 | |
| Bensen Daniel | TYRA | Chief Operating Officer | Nov 14, 2025 | Sell | $16.02 | 110,228 | $1,765,488.81 | 162,981 | |
| Bensen Daniel | TYRA | Chief Operating Officer | Nov 13, 2025 | Sell | $16.00 | 1,111 | $17,780.00 | 162,981 |
Latest Tyra Biosciences Inc. News
TYRA Breaking Stock News: Dive into TYRA Ticker-Specific Updates for Smart Investing
Compare TYRA vs Leading Stocks
See how TYRA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TYRA Tyra Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.